• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳晕下蓝色染料和肿瘤周围绿色染料注射双重定位可降低早期乳腺癌单纯染料前哨淋巴结活检的假阴性率:两点注射比一点注射更准确。

Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.

作者信息

Anan Keisei, Mitsuyama Shoshu, Kuga Hirotaka, Saimura Michiyo, Tanabe Yoshitaka, Suehara Nobuhiro, Matsunaga Hiroaki, Nishihara Kazuyoshi, Abe Yuji, Iwashita Toshimitsu, Ihara Takaaki, Tamae Keiyoshi, Ono Minoru, Toyoshima Satoshi

机构信息

Department of Surgery, Kitakyushu Municipal Medical Center Fukuoka, Japan.

出版信息

Surgery. 2006 May;139(5):624-9. doi: 10.1016/j.surg.2005.11.007.

DOI:10.1016/j.surg.2005.11.007
PMID:16701094
Abstract

BACKGROUND

The optimum sentinel node biopsy (SNB) mapping method for breast cancer remains to be determined. No matter which mapping agents are used, 2-site injection may be superior to 1-site injection in limiting the false-negative rate.

METHODS

We examined whether a double-mapping method with subareolar injection of blue dye and peritumoral injection of green dye would decrease the false-negative rate of dye-only SNB in 145 patients with early breast cancer.

RESULTS

The identification rate for blue-dyed and/or green-dyed (including mixed color-dyed) lymph nodes was 96.6% (140/145). Sensitivity and specificity were 95.1% (39/41) and 100% (99 of 99), respectively. Accuracy was 98.6% (138/140) with a false-negative rate of 4.9% (2/41). There were 4 patients in whom nodes of each color were found, but nodes of only 1 color were shown to be positive. The primary tumors of these 4 patients and of the 2 patients with false-negative results were located in the upper-outer quadrant of the breast. When only blue-dyed or green-dyed nodes (including mixed color-dyed nodes) were counted, the false-negative rates were 10.3% (4/39) for the subareolar mapping technique and 10.0% (4/40) for the peritumoral mapping technique.

CONCLUSIONS

The double-mapping method based on subareolar and peritumoral injections decreases the false-negative rate of dye-only SNB for early breast cancer. Variations in lymphatic channels may exist in the lateral half of the breast and thus may influence identification of positive sentinel nodes. This finding should be taken into account in cases of multicentric breast cancer.

摘要

背景

乳腺癌前哨淋巴结活检(SNB)的最佳定位方法仍有待确定。无论使用哪种定位剂,在限制假阴性率方面,两点注射可能优于单点注射。

方法

我们研究了在145例早期乳腺癌患者中,采用乳晕下注射蓝色染料和瘤周注射绿色染料的双重定位方法是否会降低单纯染料法SNB的假阴性率。

结果

蓝色染料和/或绿色染料(包括混合染色)标记淋巴结的识别率为96.6%(140/145)。灵敏度和特异性分别为95.1%(39/41)和100%(99/99)。准确率为98.6%(138/140),假阴性率为4.9%(2/41)。有4例患者发现了每种颜色的淋巴结,但仅1种颜色的淋巴结显示为阳性。这4例患者以及2例假阴性结果患者的原发肿瘤均位于乳房的外上象限。当仅计算蓝色染料或绿色染料标记的淋巴结(包括混合染色的淋巴结)时,乳晕下定位技术的假阴性率为10.3%(4/39),瘤周定位技术的假阴性率为10.0%(4/40)。

结论

基于乳晕下和瘤周注射的双重定位方法可降低早期乳腺癌单纯染料法SNB的假阴性率。乳房外侧半部可能存在淋巴管变异,从而可能影响前哨淋巴结阳性的识别。在多中心乳腺癌病例中应考虑这一发现。

相似文献

1
Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.乳晕下蓝色染料和肿瘤周围绿色染料注射双重定位可降低早期乳腺癌单纯染料前哨淋巴结活检的假阴性率:两点注射比一点注射更准确。
Surgery. 2006 May;139(5):624-9. doi: 10.1016/j.surg.2005.11.007.
2
Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.乳腺癌前哨淋巴结活检中瘤周及乳晕下注射的补充方法
J Surg Oncol. 2009 Aug 1;100(2):100-5. doi: 10.1002/jso.21308.
3
Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.乳腺癌前哨淋巴结活检中瘤周注射锝99m胶体与乳晕下注射蓝色染料的一致性
J Surg Res. 2007 Nov;143(1):126-9. doi: 10.1016/j.jss.2007.02.054.
4
[Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].[亚甲蓝与碳纳米颗粒混悬液注射法检测早期乳腺癌前哨淋巴结的比较]
Zhonghua Zhong Liu Za Zhi. 2011 Mar;33(3):226-8.
5
[Application of sentinel lymph node biopsy by subareolar injection of blue dye in the treatment of breast carcinoma].乳晕下注射蓝色染料法前哨淋巴结活检在乳腺癌治疗中的应用
Zhonghua Wai Ke Za Zhi. 2004 Jul 7;42(13):806-7.
6
Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.在识别乳腺癌前哨淋巴结方面,皮内放射性同位素优于瘤周蓝色染料或放射性同位素。
J Am Coll Surg. 2004 Oct;199(4):561-6. doi: 10.1016/j.jamcollsurg.2004.06.018.
7
Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.吲哚菁绿荧光引导下的乳腺癌前哨淋巴结活检
Br J Surg. 2009 Nov;96(11):1289-94. doi: 10.1002/bjs.6721.
8
Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.乳晕下和乳晕周围注射技术用于乳腺前哨淋巴结活检的验证
Arch Surg. 2004 Jun;139(6):614-8; discussion 618-20. doi: 10.1001/archsurg.139.6.614.
9
[Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].[亚甲蓝染料在乳腺癌前哨淋巴结活检中的应用及其影响因素]
Ai Zheng. 2007 Oct;26(10):1133-7.
10
[Cause of failure and false negative result in sentinel lymph node biopsy through vital blue injection in breast carcinoma].[通过注射活性蓝色染料进行乳腺癌前哨淋巴结活检失败的原因及假阴性结果]
Zhonghua Zhong Liu Za Zhi. 2002 May;24(3):297-9.

引用本文的文献

1
Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.吲哚菁绿与常规示踪剂在乳腺癌前哨淋巴结活检中的比较:临床有效性、安全性、组织和经济影响的多学科评估。
PLoS One. 2024 Aug 29;19(8):e0309336. doi: 10.1371/journal.pone.0309336. eCollection 2024.
2
An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer-Experiences After 150 Cases.用于乳腺癌前哨淋巴结检测的低于20MBq活性的超低剂量1日方案——150例后的经验
Technol Cancer Res Treat. 2017 Dec;16(6):1079-1082. doi: 10.1177/1533034617728862. Epub 2017 Sep 6.
3
Breast Cancer Sentinel Node Detection: An Alternative Solution for Centers Lacking Nuclear Technology.乳腺癌前哨淋巴结检测:缺乏核技术的中心的替代解决方案。
Breast Care (Basel). 2016 Aug;11(4):265-268. doi: 10.1159/000448409. Epub 2016 Aug 15.
4
Risk of node metastasis of sentinel lymph nodes detected in level II/III of the axilla by single-photon emission computed tomography/computed tomography.通过单光子发射计算机断层扫描/计算机断层扫描在腋窝II/III水平检测到的前哨淋巴结的淋巴结转移风险。
Exp Ther Med. 2014 Nov;8(5):1447-1452. doi: 10.3892/etm.2014.1968. Epub 2014 Sep 15.
5
Nodal status assessment in breast cancer: strategies of clinical grounds and quality of life implications.乳腺癌的淋巴结状态评估:基于临床依据的策略及对生活质量的影响
Int J Breast Cancer. 2014;2014:469803. doi: 10.1155/2014/469803. Epub 2014 Feb 11.
6
The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.EANM 和 SNMMI 乳腺癌淋巴闪烁显像和前哨淋巴结定位实践指南。
Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1932-47. doi: 10.1007/s00259-013-2544-2. Epub 2013 Oct 2.
7
The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.乳腺癌患者前哨淋巴结活检的假阴性率:一项荟萃分析。
World J Surg. 2012 Sep;36(9):2239-51. doi: 10.1007/s00268-012-1623-z.
8
Current status of sentinel lymph-node biopsy in patients with breast cancer.乳腺癌前哨淋巴结活检的现状。
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):562-75. doi: 10.1007/s00259-010-1577-z. Epub 2010 Aug 11.
9
Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer.对比非触诊乳腺癌患者施行淋巴管显影和前哨淋巴结活检的 1 天方案与 2 天方案。
Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1383-7. doi: 10.1007/s00259-009-1114-0. Epub 2009 Mar 25.